Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Cardiovascular Risk in Postmenopausal Women with Metabolic Syndrome
NCT01342744Phase 4Unknown
- Sponsor
- Mahidol University
- Start
- Apr 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in metabolic syndrome, sponsored by Mahidol University. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT01342744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342744.